DUBLIN–(BUSINESS WIRE)–The “Pharma Supply Chain & Security World 2020” conference has been added to ResearchAndMarkets.com’s offering.

The Annual Pharma Supply Chain and Security World Summit is back in London for the 3rd time, and this time with more focus on optimizing your supply chain challenges to ensure an agile, responsive, streamlined and secured supply chain. Pharmaceutical companies have to resist the challenges looming from supply chain security lapses to avoid infiltration of counterfeit, diverted, and adulterated drugs entering into the supply chain.

Apart from having an end to end visibility and traceability within the supply chain, effective serialization programs will be a key differentiator and will be a competitive advantage for the pharmaceutical companies. Drug counterfeiting which is not only a global public health risk but also harms the quality of the product, the integrity of the brand, the economy and even national security. Revenues from the pharma and bio-pharma counterfeit market are estimated to be more than $200 billion. Aligning your anti-counterfeiting strategy with the corporate supply chain strategy should plot a roadmap for implementing anti-counterfeiting measures.

Both industry and governments across the world recognising the importance of implementing product serialization, it becomes obligatory for all entities within the supply chain to comply with federal or state legislation pertaining to the locations in which they operate.

Initiatives focusing on supply chain monitoring, such as mass serialisation, track and trace or hologram tagging, had mixed outcomes, as counterfeiters are agile and have found ways to bypass the steps quickly. Pharmaceutical companies and regulators are still developing techniques to stop them by creating an intelligence-led brand protection strategy. This also reveals numerous gaps in the governmental and industry efforts to safeguard global pharmaceutical and biotech supplies.

You are invited to attend the Pharma Supply Chain & Security World 2020 – Supply-chain, Drug Serialization And Anti-Counterfeiting conference, which will have Pharma industry experts sharing various challenges faced, new strategies, case studies and use of innovative ideas, the conference will also offer opportunities to encourage partnerships and collaborations. In this conference, you’ll not only discover innovative technologies, transformation strategies and collaboration methods but how best to implement them to optimise your supply chain processes and strategies for drug anti-counterfeiting.

Key Highlights

• Streamlining your supply chain
• End to End supply chain
• Designing an optimal supply chain network
• Developing a sustainable Serialization strategy
• Integration of track & trace solutions in production and supply chain
• Smart Packaging, Labelling, Artwork, Warehouse & Logistics
• Serialization Data and Analytics-driven approach to increase supply chain agility
• Adoption of Blockchain in pharma supply chain
• Brand Protection & Securing supply chain integrity
• Global enterprise-level solutions for anti-counterfeiting
• Tackling pharmaceutical crime – initiatives at multinational, EU and national level
• IP and regulatory enforcement
• Synchrony of the Pharma Industry and professional bodies against counterfeiting
• Understanding and meeting the needs of DSCSA, EU FMD and other global regulations
• Strategies for public awareness and patient protection
• Best practices to protect your brand
• The role of the Internet in aiding the counterfeiters – How to overcome the situation?
• Effective Authentication Technologies
• Best selection of tamper-evident features
• Developing an RMP for your supply chain to protect your Brand, Product and Patient Safety
• The need to understand and adopt new technologies like IoT, Analytics, Blockchain, Machine Learning and Artificial Intelligence
• Case study: How companies are structuring their counterfeiting efforts and departments?

Who Should Attend:

Attendees include GMs, VPs, Directors, Heads and Managers of:

• Pharmaceutical manufacturers and distributors
• Supply Chain management companies
• Healthcare professionals
• Pharmacists
• Serialization, Track and Trace solution providers
• Brand protection, enforcement, security, integrity and management companies
• Healthcare research organizations
• Pharmaceutical industry professional associations
• Anti-counterfeiting organizations
• Packaging & labelling companies
• Authentication technology suppliers
• Contract manufacturing organization (CMO)
• IT service providers
• Intellectual Property, investigators and Trademark council
• Drug regulatory agencies and customs

For more information about this conference visit https://www.researchandmarkets.com/r/bp3nrn

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

DUBLIN–(BUSINESS WIRE)–The “Pharma Supply Chain & Security World 2020” conference has been added to ResearchAndMarkets.com’s offering.

The Annual Pharma Supply Chain and Security World Summit is back in London for the 3rd time, and this time with more focus on optimizing your supply chain challenges to ensure an agile, responsive, streamlined and secured supply chain. Pharmaceutical companies have to resist the challenges looming from supply chain security lapses to avoid infiltration of counterfeit, diverted, and adulterated drugs entering into the supply chain.

Apart from having an end to end visibility and traceability within the supply chain, effective serialization programs will be a key differentiator and will be a competitive advantage for the pharmaceutical companies. Drug counterfeiting which is not only a global public health risk but also harms the quality of the product, the integrity of the brand, the economy and even national security. Revenues from the pharma and bio-pharma counterfeit market are estimated to be more than $200 billion. Aligning your anti-counterfeiting strategy with the corporate supply chain strategy should plot a roadmap for implementing anti-counterfeiting measures.

Both industry and governments across the world recognising the importance of implementing product serialization, it becomes obligatory for all entities within the supply chain to comply with federal or state legislation pertaining to the locations in which they operate.

Initiatives focusing on supply chain monitoring, such as mass serialisation, track and trace or hologram tagging, had mixed outcomes, as counterfeiters are agile and have found ways to bypass the steps quickly. Pharmaceutical companies and regulators are still developing techniques to stop them by creating an intelligence-led brand protection strategy. This also reveals numerous gaps in the governmental and industry efforts to safeguard global pharmaceutical and biotech supplies.

You are invited to attend the Pharma Supply Chain & Security World 2020 – Supply-chain, Drug Serialization And Anti-Counterfeiting conference, which will have Pharma industry experts sharing various challenges faced, new strategies, case studies and use of innovative ideas, the conference will also offer opportunities to encourage partnerships and collaborations. In this conference, you’ll not only discover innovative technologies, transformation strategies and collaboration methods but how best to implement them to optimise your supply chain processes and strategies for drug anti-counterfeiting.

Key Highlights

• Streamlining your supply chain
• End to End supply chain
• Designing an optimal supply chain network
• Developing a sustainable Serialization strategy
• Integration of track & trace solutions in production and supply chain
• Smart Packaging, Labelling, Artwork, Warehouse & Logistics
• Serialization Data and Analytics-driven approach to increase supply chain agility
• Adoption of Blockchain in pharma supply chain
• Brand Protection & Securing supply chain integrity
• Global enterprise-level solutions for anti-counterfeiting
• Tackling pharmaceutical crime – initiatives at multinational, EU and national level
• IP and regulatory enforcement
• Synchrony of the Pharma Industry and professional bodies against counterfeiting
• Understanding and meeting the needs of DSCSA, EU FMD and other global regulations
• Strategies for public awareness and patient protection
• Best practices to protect your brand
• The role of the Internet in aiding the counterfeiters – How to overcome the situation?
• Effective Authentication Technologies
• Best selection of tamper-evident features
• Developing an RMP for your supply chain to protect your Brand, Product and Patient Safety
• The need to understand and adopt new technologies like IoT, Analytics, Blockchain, Machine Learning and Artificial Intelligence
• Case study: How companies are structuring their counterfeiting efforts and departments?

Who Should Attend:

Attendees include GMs, VPs, Directors, Heads and Managers of:

• Pharmaceutical manufacturers and distributors
• Supply Chain management companies
• Healthcare professionals
• Pharmacists
• Serialization, Track and Trace solution providers
• Brand protection, enforcement, security, integrity and management companies
• Healthcare research organizations
• Pharmaceutical industry professional associations
• Anti-counterfeiting organizations
• Packaging & labelling companies
• Authentication technology suppliers
• Contract manufacturing organization (CMO)
• IT service providers
• Intellectual Property, investigators and Trademark council
• Drug regulatory agencies and customs

For more information about this conference visit https://www.researchandmarkets.com/r/bp3nrn

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900